病例260:支气管内移植后淋巴增殖性疾病
31岁女性双侧肺移植后10个月,因咳嗽就诊,肺功能提示新发阻塞性通气障碍,胸部X线、CT及18F-FDG PET/CT显示支气管内病变,最终诊断为支气管内移植后淋巴增殖性疾病。
要点
- 肺移植后患者出现新发咳嗽和阻塞性通气障碍时,需将移植后淋巴增殖性疾病纳入鉴别诊断。
- 支气管内移植后淋巴增殖性疾病可表现为气道内病变,影像上需注意与感染、肿瘤等鉴别。
- 18F-FDG PET/CT有助于显示病变的代谢活性,辅助诊断和分期。
核心结论
- 病例最终诊断为支气管内移植后淋巴增殖性疾病,影像学检查在发现和评估病变中起重要作用。
研究设计与样本
- 病例报告,1例31岁女性双侧肺移植后10个月,行胸部X线、CT及18F-FDG PET/CT检查。
关键影像表现/征象
- 胸部X线和CT显示支气管内病变,具体征象见原文图1-3。
- 18F-FDG PET/CT显示病变的代谢活性,具体表现见原文图4。
临床应用与阅片要点
- 肺移植后患者出现呼吸道症状和肺功能下降时,应考虑到支气管内移植后淋巴增殖性疾病的可能。
- 影像学检查包括CT和PET/CT可用于评估气道病变及代谢活性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
History A 31-year-old woman with a history of bilateral orthotopic lung transplantation performed 10 months earlier for cystic fibrosis presented for a routine follow-up appointment, with her chief symptom being a cough. The cough started approximately 1 month prior to this appointment and was minimally productive of clear to yellow phlegm. In addition to her cough, she reported increased sinus congestion and a sensation of "something in her upper chest." She denied shortness of breath, wheezing, hemoptysis, or cigarette smoking. Review of systems was negative for fever, chills, or night sweats. At physical examination, the patient was afebrile, borderline tachycardic (heart rate, 99 beats per minute), and mildly hypertensive (blood pressure, 138/99 mm Hg). Oxygen saturation was 96% on room air. Laboratory evaluation revealed a white blood cell count of 3.5 × 109/L (normal range, [3.2-9.8] × 109/L). Pulmonary function testing was notable for a newly decreased ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) of 64% (2.0 and 3.4 L, respectively) (normal FEV1-to-FVC ratio, 80%), suggesting an obstructive lung process. One month prior to presentation, the patient's sputum cultures grew Pseudomonas and methicillin-resistant Staphylococcus aureus. The patient showed no evidence of active infection at the time of bronchoscopy. Thus, the bacteria were favored to reflect colonization, and antibiotic therapy was not administered at that time. The patient was taking an immunosuppression regimen of mycophenolate mofetil (CellCept; Genentech, San Francisco, Calif) (1 g twice daily), prednisone (10 mg daily), and tacrolimus (Prograf; Astellas Pharma US, Northbrook, Ill) (goal therapeutic range, 12-14 ng/mL). The patient was sent for posteroanterior and lateral chest radiography followed by chest CT ( Figs 1 - 3 ) and fluorine 18 (18F) fluorodeoxyglucose (FDG) PET/CT ( Fig 4 ).
引用
- Short RG, Tailor TD. Case 260: Endobronchial Posttransplantation Lymphoproliferative Disease. Radiology. 2018. PMID: 30452335. doi:10.1148/radiol.2018161689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。